SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-025613
Filing Date
2019-10-16
Accepted
2019-10-16 16:27:58
Documents
1
Period of Report
2019-01-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9490
  Complete submission text file 0000899243-19-025613.txt   10900
Mailing Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601 512-498-2670
XERIS PHARMACEUTICALS INC (Issuer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XERIS PHARMACEUTICALS 180 N. LASALLE STREET, SUITE 1800 CHICAGO IL 60601
Business Address
PRESTRELSKI STEVEN (Reporting) CIK: 0001744027 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38536 | Film No.: 191153029